Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Braskem S.A. ADR (NYSE: BAK) closed the day trading at $3.15 down -2.78% from the previous closing price of $3.24. In other words, the price has decreased by -$2.78 from its previous closing price. On the day, 0.92 million shares were traded. BAK stock price reached its highest trading level at $3.2492 during the session, while it also had its lowest trading level at $3.14.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BAK now has a Market Capitalization of 1352765824 and an Enterprise Value of 58124206080. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.04. Its current Enterprise Value per Revenue stands at 0.748 whereas that against EBITDA is 23.841.
Stock Price History:
The Beta on a monthly basis for BAK is 1.80, which has changed by -0.5387994 over the last 52 weeks, in comparison to a change of 0.1653893 over the same period for the S&P500. Over the past 52 weeks, BAK has reached a high of $7.71, while it has fallen to a 52-week low of $2.80. The 50-Day Moving Average of the stock is -2.28%, while the 200-Day Moving Average is calculated to be -16.23%.
Shares Statistics:
Over the past 3-months, BAK traded about 931.03K shares per day on average, while over the past 10 days, BAK traded about 586300 shares per day. A total of 172.53M shares are outstanding, with a floating share count of 172.20M. Shares short for BAK as of 1756425600 were 3427374 with a Short Ratio of 3.68, compared to 1753920000 on 3729760. Therefore, it implies a Short% of Shares Outstanding of 3427374 and a Short% of Float of 3.61.
Earnings Estimates
The market rating of Braskem S.A. ADR (BAK) is currently shaped by the ongoing analysis conducted by 1.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.42, with high estimates of -$0.42 and low estimates of -$0.42.
Analysts are recommending an EPS of between $0.4 and $0.4 for the fiscal current year, implying an average EPS of $0.4. EPS for the following year is -$0.83, with 1.0 analysts recommending between -$0.83 and -$0.83.
Revenue Estimates
2 analysts predict $19.56B in revenue for. The current quarter. It ranges from a high estimate of $19.73B to a low estimate of $19.39B. As of. The current estimate, Braskem S.A. ADR’s year-ago sales were $21.27BFor the next quarter, 2 analysts are estimating revenue of $20.12B. There is a high estimate of $20.18B for the next quarter, whereas the lowest estimate is $20.05B.
A total of 10 analysts have provided revenue estimates for BAK’s current fiscal year. The highest revenue estimate was $80.05B, while the lowest revenue estimate was $72.99B, resulting in an average revenue estimate of $76.66B. In the same quarter a year ago, actual revenue was $77.41BBased on 10 analysts’ estimates, the company’s revenue will be $84.19B in the next fiscal year. The high estimate is $90.67B and the low estimate is $79.01B.
